9-135702290-G-A
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_020822.3(KCNT1):c.32G>A(p.Gly11Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,609,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G11A) has been classified as Uncertain significance.
Frequency
Consequence
NM_020822.3 missense
Scores
Clinical Significance
Conservation
Publications
- ovarian dysgenesis 5Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- hypogonadismInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020822.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNT1 | NM_020822.3 | MANE Select | c.32G>A | p.Gly11Glu | missense | Exon 1 of 31 | NP_065873.2 | ||
| KCNT1 | NM_001272003.2 | c.32G>A | p.Gly11Glu | missense | Exon 1 of 31 | NP_001258932.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNT1 | ENST00000371757.7 | TSL:1 MANE Select | c.32G>A | p.Gly11Glu | missense | Exon 1 of 31 | ENSP00000360822.2 | ||
| KCNT1 | ENST00000460750.5 | TSL:1 | n.32G>A | non_coding_transcript_exon | Exon 1 of 32 | ENSP00000418777.1 | |||
| KCNT1 | ENST00000487664.5 | TSL:5 | c.32G>A | p.Gly11Glu | missense | Exon 1 of 32 | ENSP00000417851.2 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152122Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000422 AC: 1AN: 236710 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000480 AC: 7AN: 1457394Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 725028 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74440 show subpopulations
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1Other:1
Variant interpreted as Likely benign and reported on 03-06-2020 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.
Inborn genetic diseases Uncertain:1
The c.32G>A (p.G11E) alteration is located in exon 1 (coding exon 1) of the KCNT1 gene. This alteration results from a G to A substitution at nucleotide position 32, causing the glycine (G) at amino acid position 11 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Developmental and epileptic encephalopathy, 14 Uncertain:1
not provided Benign:1
Has not been previously published as pathogenic or benign to our knowledge
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at